[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369805-105":59,"doc-detail-369805-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","anamorelin-as-a-therapeutic-option-for-cancer-cachexia-in-advanced-pancreatic-cancer-a-case-report-demonstrating-significant-weight-gain-and-quality-of-life-improvement","Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer - A Case Report Demonstrating Significant Weight Gain and Quality of Life Improvement","","Cancer cachexia marked by weight loss and muscle weakness is common in pancreatic cancer patients. Anamorelin, a ghrelin receptor agonist, is reported to help manage cachexia, but pancreatic cancer evidence in real-world settings remains limited. This case describes a 64-year-old man with unresectable pancreatic cancer who showed significant weight gain with anamorelin. The response supported continued chemotherapy and improved quality of life despite disease progression. Further research is required to confirm its utility in this population.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anamorelin-as-a-therapeutic-option-for-cancer-cachexia-in-advanced-pancreatic-cancer-a-case-report-demonstrating-significant-weight-gain-and-quality-of-life-improvement/369805/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anamorelin-as-a-therapeutic-option-for-cancer-cachexia-in-advanced-pancreatic-cancer-a-case-report-demonstrating-significant-weight-gain-and-quality-of-life-improvement/369805.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is cancer cachexia and why is it important in pancreatic cancer?","Question",{"text":112,"@type":113},"Cancer cachexia involves decreased appetite, weight loss, and muscle weakness. It is common among cancer patients and contributes to malnutrition and reduced quality of life, particularly in pancreatic cancer where prevalence is high.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was anamorelin used in the reported case?",{"text":117,"@type":113},"A 64-year-old man with unresectable pancreatic cancer received anamorelin and experienced significant weight gain. This allowed continuation of chemotherapy and helped improve quality of life.",{"name":119,"@type":110,"acceptedAnswer":120},"Did the patient respond to anamorelin despite disease progression?",{"text":121,"@type":113},"Yes. The patient’s response suggested potential utility of anamorelin as supportive therapy, even though disease progression occurred.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369805,1790310318,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","doi: 10.2169/internalmedicine.4708-24  \nIntern Med 64: 2312-2316, 2025  \n[http://internmed.jp](http://internmed.jp)  \n【CASE REPORT】  \nAnamorelin as a Therapeutic Option for Cancer Cachexiain Advanced Pancreatic Cancer: A Case Report Demonstrating Significant Weight Gain and Quality of Life  \nImprovement  \nMotoyasu Kan 1,2, Yoshiki Ogane 1, Kazuki Watabe 1, Tomoya Takahashi 1, Miho Sakai 1, Yu Sekine 1, Nana Yamada 1, Chihei Sugihara 1, Mayu Ouchi 1, Hiroki Nagashima 1, Koji Takahashi 2, Koichiro Okitsu 1, Hiroshi Ohyama 1, Izumi Ohno 2 and Naoya Kato 1  \n\n| Abstract:\u003Cbr>Cancer cachexia, which is characterized by weight loss and muscle weakness, is common in patients with pancreatic cancer. Anamorelin, a ghrelin receptor agonist, has shown potential for the management of cachexia in various cancers. We herein report a 64-year-old man with unresectable pancreatic cancer who experienced significant weight gain with anamorelin, allowing for continued chemotherapy and an improved quality of life. Despite disease progression, his response suggests the potential utility of anamorelin as a supportive therapy. Cachexia’s complex metabolic changes make treatment difficult; however, anamorelin’s appetite and weight gain effects highlight its possible role in managing cachexia in pancreatic cancer. Therefore, further research is required in this regard.\u003Cbr>Key words: pancreatic cancer, supportive care, cancer cahexia, ghrelin, anamorelin\u003Cbr>(Intern Med 64: 2312-2316, 2025)\u003Cbr>(DOI: 10.2169/internalmedicine.4708-24) |  |\n| --- | --- |\n| \u003Cbr>Introduction\u003Cbr>Cancer cachexia is characterized by symptoms of a decreased appetite, weight loss, and muscle weakness. It is reported to occur in 50-80% of cancer patients (1) and is considered an important pathophysiology contributing to malnutrition and a decreased quality of life (QOL) . The prevalence of pancreatic cancer is particularly high, with approximately half of patients presenting at the diagnosis, and the cumulative incidence rate is 71.3%, including after the initiation of treatment (2) .\u003Cbr>Therapies for cancer cachexia have long been elusive; however, in recent years, anamorelin, a ghrelin receptor agonist, has been found to be effective. It is currently approved for clinical use only in Japan based on the ONO-7643-04 and ONO-7643-05 trials (3, 4) . These trials demonstrated | the efficacy of anamorelin in maintaining or increasing lean body mass in patients with non-small-cell lung, gastric, colorectal, and pancreatic cancers, thereby improving cachexia and the nutritional status. Consequently, anamorelin is considered to be a treatment option for cancer cachexia. However, the number of patients with pancreatic cancer in these\u003Cbr>clinical trials is limited, and reports on the effectiveness of anamorelin for pancreatic cancer in real-world settings are scarce.\u003Cbr>We herein report a case in which significant weight gain was observed with anamorelin, which contributed to the continuation of chemotherapy and maintenance of the QOL.\u003Cbr>\u003Cbr>Case Report\u003Cbr>A 64-year-old man presented to our hospital with a chief complaint of black stool. He was found to have severe ane- |\n\n1 Department of Gastroenterology, Graduate School of Medicine, Chiba University, Japan and 2 Department of Oncology, Graduate School of Medicine, Chiba University, Japan  \nReceived: September 17, 2024; Accepted: December 10, 2024; Advance Publication by J-STAGE: February 8, 2025  \nCorrespondence to Motoyasu Kan, [kan.motoyasu@chiba-u.jp](kan.motoyasu@chiba-u.jp)  \nFigure 1. Initial upper gastrointestinal endoscopic images at our hospital. (A) An extensive ulcerative lesion was observed in the duodenal bulb, with a visible vessel at the base of the ulcer (yellow arrowheads). (B) Cauterization confirmed the disappearance of the visible vessel (yellow arrowheads).  \nFigure 2. Contrast-enhanced computed tomography images. (A) Axial section image. (B) Coronal section image. A tumor >30 mm in size with poor contrast was observed","cbCaica7iv3xkw4D","https://ap.wps.com/l/cbCaica7iv3xkw4D","pdf",793804,"English","# Introduction\n## Case Report","[{\"question\":\"What is cancer cachexia and why is it important in pancreatic cancer?\",\"answer\":\"Cancer cachexia involves decreased appetite, weight loss, and muscle weakness. It is common among cancer patients and contributes to malnutrition and reduced quality of life, particularly in pancreatic cancer where prevalence is high.\"},{\"question\":\"How was anamorelin used in the reported case?\",\"answer\":\"A 64-year-old man with unresectable pancreatic cancer received anamorelin and experienced significant weight gain. This allowed continuation of chemotherapy and helped improve quality of life.\"},{\"question\":\"Did the patient respond to anamorelin despite disease progression?\",\"answer\":\"Yes. The patient’s response suggested potential utility of anamorelin as supportive therapy, even though disease progression occurred.\"}]","Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer - A Case Report Demonstrating Significant Weight Gain and Quality of Life Improvement | PDF",1790184645,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1cd3df3cec5b304a6f4dce9a83a5b76.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dff8db393f69e23a2aa1a3ab1f866c5d.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcc4d713577b6bd7cdbe3e088385816a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/678a88e57c330fd20d10664ad9563f38.webp",980,1386]